Reimbursement Past Sema denied for missing prior authorization by Aetna?

Aetna's specific coverage criteria for reimbursement past sema are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Requires Prior Authorization for Semaglutide

Aetna routinely places semaglutide on a tier that requires prior authorization (PA) before claims will be paid. This is a utilization-management tool, not an outright denial of coverage — it means the plan wants to confirm, in advance, that clinical criteria are met. A claim submitted without a valid PA on file will be automatically denied, but the underlying coverage may still be available once authorization is obtained or retroactively approved.

## Why This Denial Is Appealable

A PA-required denial is appealable on two tracks: (1) a standard internal appeal arguing that medical necessity existed at the time of service and that the PA was either improperly denied or should be approved retroactively, and (2) a prospective appeal for ongoing or future fills. Retroactive authorization is granted when plans agree that the clinical criteria were met even though the administrative step was missed.

## Federal Appeal Framework

• Internal appeal: ACA §2719 and ERISA §503 guarantee a full-and-fair internal review. The denial letter must state the exact clinical criteria Aetna used and the reason they were not satisfied — if it does not, that itself is grounds for appeal.
• External review: After exhausting internal appeals, an independent external review is available within approximately four months of the final denial. External reviewers apply objective clinical standards.
• Expedited review: Available when the standard timeline would seriously jeopardize health; request this simultaneously with a standard appeal if urgency applies.

## Documentation to Gather

1. Prescriber letter of medical necessity — must address each criterion listed in Aetna's current PA criteria for semaglutide, available from Aetna's provider portal. The letter should confirm the applicable FDA-approved indication and that the patient meets every stated requirement. 2. Diagnosis and clinical history — office notes, lab results (referenced by date and clinical interpretation, not raw numbers), and any specialist evaluations confirming the underlying condition. 3. Prior-treatment history — dated records of any prior therapies tried, with outcomes and reasons for transition, to demonstrate the clinical pathway leading to this prescription. 4. Current FDA prescribing information — attach the relevant indication section to confirm alignment between the prescription and the labeled use.

## Criteria-Mapping Structure

Download Aetna's published PA criteria for semaglutide. Then build a point-by-point response:

| Aetna PA Criterion (copy verbatim) | Chart Evidence (document + date) | |---|---| | Qualifying diagnosis requirement | Diagnosis note, ICD code | | Prior therapy requirement (if any) | Dated medication history | | Prescriber specialty or attestation requirement | Prescriber credentials / letter | | Any additional clinical threshold | Corresponding chart documentation |

Address every criterion explicitly. Unanswered criteria are the most common reason a PA appeal fails at the first internal review.